Neochem Bio Solutions Limited
Neochem Bio Solutions has scheduled a board meeting on May 18, 2026, to approve its audited financial results for the half year and full year ended March 31, 2026. This meeting will finalize the company's financial performance for the period.
May 11 2026 18:05:00
Neochem Bio Solutions Limited
Neochem Bio Solutions board is scheduled to meet on May 18, 2026, to consider and approve its audited standalone half-yearly financial results for the period ended March 2026. This meeting will finalize the company's performance for the second half of the fiscal year 2026.
May 09 2026 11:05:00
Neochem Bio Solutions Limited
Neochem Bio Solutions board is scheduled to meet on May 18, 2026, to consider and approve its audited standalone half-yearly financial results for the period ended March 2026. This meeting will finalize the company's performance for the second half of the fiscal year 2026.
May 09 2026 11:05:00
Neochem Bio Solutions Limited
Neochem Bio Solutions has scheduled a board meeting on May 18, 2026, to approve its audited financial results for the half year and full year ended March 31, 2026. This meeting will finalize the company's financial performance for the period.
May 09 2026 11:05:00
Neochem Bio Solutions Limited
Neochem Bio Solutions Limited states it is not a 'large corporate' for FY2025-26, thereby exempting it from certain SEBI disclosure requirements. This means the company is not obligated to comply with Chapter XII disclosures for debt security issuance for the period.
Apr 23 2026 16:04:00
Neochem Bio Solutions Limited (NEOCHEM)
Neochem Bio Solutions is exempted from submitting its Q4 FY26 corporate governance report. This is due to the company's listing on the NSE EMERGE SME Platform and its paid-up capital not exceeding ₹10 crore and net worth not exceeding ₹25 crore.
Apr 15 2026 16:04:00
Read More